Abobotulinumtoxin A

abobotulinumtoxin A · Ipsen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Abobotulinumtoxin A, covering 2025-10-21 to 2025-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Chronic Exertional Compartment Syndrome (CECS) Treated With Abobotulinumtoxin A [Phase 4]